Dominique Rebouillat

Title: The Innovations of Dominique Rebouillat

Introduction

Dominique Rebouillat is a notable inventor based in Paris, France. He has made significant contributions to the field of biochemistry, particularly in the development of caspase-2 inhibitors. His work focuses on innovative solutions for preventing and treating diseases associated with caspase-2 activity.

Latest Patents

Rebouillat holds a patent for "Caspase-2 inhibitors and their biological applications." This invention relates to selective new caspase-2 inhibitors that recognize caspase-2 and prevent and block its activity. The backbone of these inhibitors is based on the compound 2-Quinolinylcarbonyl-L-Valinyl-L-Aspartyl (methyl ester)-L-Valinyl-L-Alanyl-L-Aspartyl (methyl ester) 2,6-difluorophenyl ester (SEQ ID NO:1) and its derivatives. The application of these inhibitors is aimed at preventing and treating diseases involving caspase-2.

Career Highlights

Dominique Rebouillat has established a successful career in the pharmaceutical industry. He is currently associated with Chiesi Farmaceutici S.p.a., where he continues to innovate and contribute to advancements in medical science. His expertise in biochemistry and pharmacology has positioned him as a key figure in his field.

Collaborations

Throughout his career, Rebouillat has collaborated with esteemed colleagues, including David Chauvier and Richard Casimir. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Dominique Rebouillat's work in developing caspase-2 inhibitors showcases his commitment to advancing medical science. His innovative contributions have the potential to significantly impact the treatment of diseases related to caspase-2 activity.